Community/Retail

This weekly video program highlights the latest in pharmacy news, product news, and more.

Black children with severe pain are less likely to receive opioids in emergency rooms than white children.

With OTC remedies for colds crowding self-help shelves, experts are divided on the merits of single-symptom treatment over multi-symptom therapy.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some of the DEA's requirements for handling controlled substances.

In recognition of American Pharmacists Month, Mel Seabright, PharmD, MBA, shares how he became a pharmacist.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines several ways in which Rite Aid demonstrates its commitment to the pharmacist's role in direct patient care.

Many pharmacists are looking to national certification as a standard by which to accurately discern a pharmacy technician's knowledge.

Ron Lanton, government affairs strategist for the Pharmacy Podcast Show, interviews Phil LaFoy of Blount Specialty Pharmacy.

340B Health is deeply disappointed with a federal district court ruling today that will significantly raise the cost of orphan drugs for rural and cancer hospitals and their patients.

Rite Aid pharmacies nationwide are once again providing free resources to help its senior customers select the right prescription drug plan or update their existing coverage during the annual Medicare Part D enrollment period.

Valeant Pharmaceuticals International has announced the expiration of the tender offer to purchase all of the outstanding shares of Synergetics USA.

Roundy's has announced that it will join EPA's GreenChill program, which is a partnership between the EPA and food retailers to reduce emissions and decrease their impact on the ozone layer and climate change.

It has been a year since the DEA reclassified all drugs containing the opioid hydrocodone as Schedule II controlled substances.

CVS just released a mobile prescription pickup service incorporated into its current mobile app.

A generic version of Avodart, used to treat the symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate, has been launched by Teva Pharmaceutical Industries Ltd.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, outlines some of the latest pharmacy services developed by Rite Aid.

The best-selling brand-name drugs are not necessarily the most-prescribed medications in the United States.

Drug-related problems such as overdose and drug-drug interactions frequently occur in patient populations at risk for polymorbidity and polypharmacy. Among these problems is proton pump inhibitor (PPI) misuse.

The National Community Pharmacists Association (NCPA) 2015 Annual Convention wrapped up today, but the following award winners can bask in their glory until the next NCPA conference in 2016.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, forecasts the ways in which pharmacy may change over the next 2-3 years.

This week, the Professional Women in Advocacy Conference named NACDS Senior Vice President of Government Affairs Carol Kelly one of three finalists for an Excellence in Advocacy Award in the Veteran Practitioner category.

Contrary to a prior theory, substituting saline with a buffered crystalloid solution doesn't reduce the risk of kidney injury or failure in the intensive care unit (ICU).

Pharmacists interested in providing more services to patients traveling domestically or abroad can tap into a big business opportunity.

The Consumer Healthcare Products Association, the trade association representing the leading manufacturers and marketers of over-the-counter medicines, released the following statement in support of yesterday's enactment of a New Jersey law prohibiting the sale of OTC medicines containing the cough suppressant dextromethorphan to minors.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), gives some tips for pharmacists on how to keep a quality, compliant compounding practice.

The placebo effect is growing stronger in US clinical trials for chronic pain medications.

A pharmacy in Kentucky will pay $9.25 million to settle claims that it received money from Abbott for promoting a drug to nursing home patients.

Students in Alaska will no longer have to leave their home state to pursue a pharmacy degree.

Graduate students will soon have the opportunity to learn about the drug discovery and development process.

Discussion around biologics, biosimilars and interchangeability has been spreading in our pharmacies and in our legislatures for years now. So what's all the fuss about?